Paper Details 
Original Abstract of the Article :
Aliskiren is the first orally active inhibitor of renin to be approved for clinical use as an antihypertensive agent. The development program has established that at the licensed doses of 150 mg and 300 mg, there are dose-related falls in blood pressure comparable to those seen with other major clas...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1161/CIRCULATIONAHA.108.787630

データ提供:米国国立医学図書館(NLM)

Aliskiren: A New Frontier in Hypertension Treatment

The field of [hypertension] is constantly evolving, with researchers searching for new and effective treatments to manage high blood pressure. This study explores the potential of [aliskiren], the first orally active inhibitor of renin, as an antihypertensive agent.

The researchers conducted a comprehensive clinical development program to evaluate the efficacy and safety of aliskiren. They found that aliskiren effectively lowered blood pressure at licensed doses, comparable to other major antihypertensive drugs. Aliskiren was shown to be effective both as monotherapy and in combination with other antihypertensive agents.

Aliskiren: A Promising Antihypertensive Agent

This research, like a camel navigating a desert with a steady supply of water, reveals the potential of aliskiren as a valuable tool in the treatment of hypertension. The findings suggest that aliskiren can effectively control blood pressure, potentially offering a new option for patients who haven't responded to other therapies.

Managing Hypertension: A Multifaceted Approach

Just as a camel adapts to the changing conditions of the desert, managing hypertension requires a multifaceted approach. This research highlights the importance of considering lifestyle modifications, such as diet and exercise, along with medication to effectively control blood pressure.

Dr.Camel's Conclusion

This study, like a caravan discovering a new oasis in a vast desert, introduces aliskiren as a promising antihypertensive agent. The findings offer hope for individuals with hypertension, paving the way for new treatment options and a brighter future for cardiovascular health.

Date :
  1. Date Completed 2008-08-29
  2. Date Revised 2012-11-15
Further Info :

Pubmed ID

18695203

DOI: Digital Object Identifier

10.1161/CIRCULATIONAHA.108.787630

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.